Centers for Disease Control and Prevention (CDC) Lowers Pneumococcal Vaccination Age to 50 Dr. Kamal Kant Kohli5 Feb 2025 10:45 AM ISTThe U.S. Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) has lowered the recommended age for...
Addressing Pneumococcal Disease in CKD Patients: A Call for Preventive Action Dr. Alan Almeida22 Jan 2025 11:49 AM ISTIn India, the prevalence of chronic kidney disease (CKD) has reached epidemic proportions, with population-based studies reporting a prevalence...
HCMCT Manipal Hospital, Dwarka, Pfizer join hands to launch Centre of Excellence for Adult Vaccination Kajal Rajput31 Aug 2024 2:15 PM ISTNew Delhi: In a country where vaccination is often associated only with childhood immunisation and the need for adult vaccines is often overlooked,...
Adult Vaccination in India: Addressing Practice Perspectives Dr. Indranil Halder29 Aug 2024 11:15 AM ISTIn India, less than 2% of adults receive routine vaccinations for diseases like influenza, pneumococcal diseases, typhoid, and hepatitis B, which...
Pfizer India, Apollo Hospital launch Centre of Excellence for adult vaccination in Hyderabad MD Bureau28 May 2023 2:00 PM ISTThe centre will immunize against various vaccine-preventable diseases such as Pneumococcal disease, Hepatitis A and B, Human Papilloma Virus (HPV),...
Pfizer gets USFDA approval for 20-valent Pneumococcal Conjugate Vaccine PREVNAR 20 for infants, children Ruchika Sharma28 April 2023 11:43 AM ISTPREVNAR 20 builds on Pfizer's approved PREVNAR 13 vaccine, and includes seven additional serotypes (8, 10A, 11A, 12F, 15B, 22F and 33F) shown to be...
Pfizer 20-Valent Pneumococcal Conjugate Vaccine for infants, children accepted by USFDA for Priority Review Ruchika Sharma8 Jan 2023 4:15 PM ISTNew York: Pfizer Inc. has announced that the U.S. Food and Drug Administration (FDA) has accepted for priority review a supplemental Biologics...
Aurobindo Pharma JV Tergene gets CDSCO panel recommendation for 15-valent Pneumococcal Polysaccharide Conjugate Vaccine Ruchika Sharma27 Dec 2022 3:42 PM ISTHyderabad: Drugmaker, Aurobindo Pharma Ltd, has announced that Subject Expert Committee (SEC) of the Central Drugs StandardControl Organization...
Merck presents positive results from Pneumococcal conjugate vaccine study Ruchika Sharma22 Jun 2022 2:30 PM ISTPneumococcal disease is an infection caused by the bacterium Streptococcus pneumoniae, or pneumococcus.
Merck gets USFDA nod for Pneumococcal 15-valent Conjugate Vaccine Ruchika Sharma18 July 2021 10:30 AM ISTKenilworth: Merck known as MSD outside the United States and Canada, has recently announced the U.S. Food and Drug Administration (USFDA) approved...
Pfizer starts Four Phase 3 Clinical Trials for Investigational Vaccines Ruchika Sharma25 Jun 2020 9:00 AM ISTNew York: Pfizer Inc. has announced the initiation of four Phase 3 clinical trials within its current pipeline of investigational vaccines:Two studies...
India introduces new vaccine to fight pneumococcal disease savita thakur thakur15 May 2017 11:50 AM ISTNew Delhi: The Centre introduced a new vaccine in its immunisation programme to protect children against diseases such as pneumonia in India, which...
